November 14-15, 2012: Vaccines and Related Biological Products Advisory Committee Meeting Member Roster

MEMBERS

CHAIR
Robert Daum, M.D., C.M.
Expertise: Molecular Med & Pediatrics
Term: 02/01/2012 – 01/31/2016
Professor of Pediatrics
Microbiology and Molecular Medicine
Director, The University of Chicago MRSA Research Center
Department of Pediatrics, Section of Infectious Diseases
5841 South Maryland Avenue, MC 6054
Chicago, IL 60637

Ambrose Cheung, M.D.
Expertise: Microbiology/Infectious Dis.
Term: 06/07/2010 – 01/31/2014
Professor of Microbiology
Dartmouth Medical School
Hanover, NH 03755

Anna Durbin, M.D. +
Expertise: Virology/Infectious Diseases
Term: 06/07/2010 – 01/31/2014
Associate Professor
Johns Hopkins Bloomberg School of Public Health
Center for Immunization Research
624 N. Broadway
Hampton House, Room 251
Baltimore, MD 21205

Gregory Gray, M.D., M.P.H.
Expertise: Epidemiology
Term: 06/07/2010 – 01/31/2014
Professor and Chair
College of Public Health and Health Professions, University of Florida
Gainesville, FL 32610

Gary Schoolnik, M.D. +
Expertise: Microbiology/Infectious Dis.
Term: 06/07/2010 – 01/31/2014
Professor of Medicine and Associate
Director
Stanford Institute for Immunology
Transplantation and Infectious Diseases
Beckman Center, Room B241A
291 Campus Drive
Stanford, CA 94305

Carol Tacket, M.D.
Expertise: Epidemiology
Term: 06/07/2010 – 01/31/2014
Adjunct Professor of Medicine
Department of Medicine
University of Maryland School of Medicine
685 W. Baltimore Street
Baltimore, MD 21201

Gillian Air, Ph.D.
Expertise: Microbiology
Term: 04/25/2011 – 01/31/2015
Vice-chair
Department of Biochemistry & Molecular Biology, BMSB-840
P.O. Box 26901
Oklahoma City, OK 73190

Edgar Marcuse, M.D., M.P.H.
Expertise: Pediatrics and Epidemiology
Term: 04/25/2011 – 01/31/2015
Associate Medical Director
Seattle Children's Hospital
4800 Sand Point Way, N.E., T-0111
P.O. Box 5371
Seattle, WA 98105

COL Kent Kester, M.D. +
Expertise: Infectious Diseases
Term: 06/16/2011 – 01/31/2015
Associate Dean for Clinical Research
Office of the Dean, School of Medicine
Uniformed Services University of the Health Sciences
4301 Jones Bridge Road
Bethesda, MD 20814

Michael Hudgens, Ph.D.
Expertise: Biostatistics
Term: 02/01/2012 – 01/31/2016
Associate Professor
Department of Biostatistics
University of North Carolina at Chapel Hill
3107-E McGavran-Greenberg
Chapel Hill, NC 27599

Pedro Piedra, M.D.
Expertise: Pediatric Infectious Diseases
Term: 02/01/2012 – 01/31/2016
Professor
Department of Molecular Virology and
Microbiology
Baylor College of Medicine
One Baylor Plaza (MS BCM 280), Rm 248E
Houston, TX 77030

Nathanael Brady, D.O. *
Expertise: Consumer Representative
Term: 03/22/2012 – 01/31/2016
Partner
Pike Peak Allergy & Asthma
595 Chapel Hills Drive
Colorado Springs, CO 80920

Theodore Tsai, M.D. ** +
Expertise: Industry Representative
Term: 03/20/2012 – 01/31/2016
Senior Vice President, Scientific Affairs
Novartis Vaccines and Diagnostics
350 Massachusetts Avenue
Cambridge, MA 02139

* Consumer Representative
** Industry Representative

+ Did not attend.

Designated Federal Officer
Donald Jehn, M.S.
DFO, Vaccines and Related Biological Products Advisory Committee
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation & Research
1401 Rockville Pike, HFM-71 Rockville, MD 20852
301-827-0314
fax # 301-827-0294
donald.jehn@fda.hhs.gov

Committee Management Specialist
Denise Royster
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation & Research
1401 Rockville Pike, HFM-71
Rockville, MD 20852
301-827-0314
fax # 301-827-0294
denise.royster@fda.hhs.gov

Jack Bennink, Ph.D.
Chief, Viral Immunology Section
Laboratory of Viral Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health
MSC 3209, 33 North Dr.
Bethesda, MD 20892

Filip Dubovsky, M.D., M.P.H., FAAP #
Vice President Clinical Development
Therapeutic Area Head
Infectious Disease and Vaccines MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878

Theodore Eickhoff, M.D. ## +
Professor Emeritus
Division of Infectious Disease
University of Colorado Health Sciences Center
12700 E. 19th Avenue, Research 2
11th Floor, Room 11016, MS B168
Aurora, CO 80045

Bruce Gellin, M.D.
Director
National Vaccine Program Office (NVPO)
Health and Human Services
200 Independence Ave., SW, Rm 715H
Washington, DC 20201

Roland Levandowski, M.D., FACP ##
Infectious Diseases Scientist
Bethesda, MD

Pamela McInnes, D.D.S., Msc (Dent.)
Director
Division of Extramural Research
National Institute of Health
6701 Democracy Blvd., Rm 610,
MS 4878
Bethesda, MD 20892

Trudy Murphy, M.D. ###
Team Lead
Vaccine Research and Policy Team
Division of Viral Hepatitis
NCHHSTP
Centers for Disease Control and Prevention
1600 Clifton Rd.
Atlanta, GA 30333

Melinda Wharton, M.D., M.P.H.
Deputy Director
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd, MS A27
Atlanta, GA 30333

# Acting Industry Representative.
## Topic 1 only.
### Topic 2 only.

Marion Gruber, Ph.D.
Director, OVRR/CBER
Food and Drug Administration
Rockville, MD

Jerry Weir, Ph.D.
Director, Division of Viral Products
OVRR/CBER
Food and Drug Administration
Rockville, MD

Wellington Sun, M.D.
Director, DVRPA
OVRR/CBER
Food and Drug Administration
Rockville, MD

Carmen Collazo-Custodio, Ph.D.
Microbiologist, DVRPA
OVRR/CBER
Food and Drug Administration
Rockville, MD

Andrea James, M.D.
Medical Officer, DVRPA
OVRR/CBER
Food and Drug Administration
Rockville, MD

Hana Golding, Ph.D.
Chief, DVP
OVRR/CBER
Food and Drug Administration
Rockville, MD

Alexandra Worobec, M.D., M.S.
Medical Officer, DVRPA
OVRR/CBER
Food and Drug Administration
Rockville, MD

Lorie Smith, M.D.
Medical Officer, DVRPA
OVRR/CBER
Food and Drug Administration
Rockville, MD
Marian Major, Ph.D.
Acting Chief, LHV
DVP/OVRR/CBER
Food and Drug Administration
Rockville, MD

Robin Robinson, Ph.D.
ASPR
Deputy Assistant Secretary and BARDA Director
Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201

Joseph Bresee, M.D.
CAPT, USPHS
Chief, Epidemiology & Prevention Branch, Influenza Division
Centers for Disease Control & Prevention
1600 Clifton Road, N.E.
Atlanta, GA

Donna Boyce
Head, North America,
Global Regulatory Affairs
GlaxoSmithKline
King of Prussia, PA, USA

Bruce Innis, M.D.
Vice President
Vaccine Discovery and Development
GlaxoSmithKline
King of Prussia, PA, USA

Felix Arellano, M.D.
Vice President
Vaccines Clinical Safety and Pharmacovigilance
GlaxoSmithKline
Wavre, Belgium

J. Tyler Martin, M.D.
Chief, Medical Officer
Dynavax Technologies Corporation
Berkeley, CA

Jesse Goodman, M.D., M.P.H.
Chief Scientist and Deputy
Commissioner for Science and Public Health, Office of the Commissioner
Food and Drug Administration
Silver Spring, MD

William Schaffner, M.D.
Professor and Chair, Department of Preventive Medicine
Vanderbilt University
Nashville, TN

Gregory Poland, M.D.
Professor of Medicine, Director of the Mayo Vaccine Research Group
Mayo Clinic
Rochester, MN

Robert Janssen, M.D.
Senior Director, Clinical Research
Dynavax Technologies Corporation
Berkeley, CA

Stanley Plotkin, M.D.
Emeritus Professor
University of Pennsylvania
Philadelphia, PA